{"meta":{"query_hash":"8f0bd56e6dde","filters":{"venue":"Neurodegenerative Disease Management"},"cohort_total":43,"direct_labels_cover":0,"predictions_cover":43,"exported":43,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8f0bd56e6dde","api":"https://metacan.xera.ac/api/v1/cohort?venue=Neurodegenerative+Disease+Management"},"results":[{"id":"W1967703150","doi":"10.2217/nmt.11.49","title":"Comparison of Exercise Strategies for Motor Symptom Improvement in Parkinson’s Disease","year":2011,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University","funders":"Parkinson Canada; Parkinson Society Canada","keywords":"Physical therapy; Physical medicine and rehabilitation; Parkinson's disease; Aerobic exercise; Rating scale; Medicine; Randomized controlled trial; Modalities; Psychology; Disease; Internal medicine","score_opus":0.04271817873463875,"score_gpt":0.3029107075431655,"score_spread":0.2601925288085268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967703150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892355,0.001355551,0.002414859,0.0001134544,0.0002675187,0.004515529,0.0004320154,0.000077284916,0.0015882738],"genre_scores_gemma":[0.9946298,0.00021613036,0.0018639725,0.00021698106,0.000038631377,0.0022367407,0.00018356334,0.000053338455,0.0005608482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776036,0.000054172393,0.000547368,0.0007636289,0.00043558513,0.00043889222],"domain_scores_gemma":[0.9984512,0.000019071189,0.0001917228,0.0006020701,0.00012119827,0.0006147585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010155968,0.0003911293,0.00054812955,0.00030413148,0.000090854606,0.00003182422,0.00017848145,0.000036405818,0.0001305515],"category_scores_gemma":[0.000016018465,0.00035251924,0.00028428325,0.0002035441,0.000072186165,0.00016362578,0.00011900761,0.00007842483,0.000013365069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044277485,0.04074709,0.7318617,0.009674229,0.0019033982,0.0024742575,0.003614177,0.0009368736,0.0072511365,0.09280656,0.003922652,0.060530443],"study_design_scores_gemma":[0.0070220763,0.0011342067,0.9661139,0.00046812824,0.001810317,2.453732e-7,0.0011983956,0.0061828,0.007844064,0.0034375712,0.0043016034,0.00048668764],"about_ca_topic_score_codex":0.000024849132,"about_ca_topic_score_gemma":0.000008923375,"teacher_disagreement_score":0.23425221,"about_ca_system_score_codex":0.00011626581,"about_ca_system_score_gemma":0.00014796153,"threshold_uncertainty_score":0.99989265},"labels":[],"label_agreement":null},{"id":"W1974924861","doi":"10.2217/nmt.11.50","title":"Implications of a New Diagnostic Blood Test for Alzheimer’s Disease On Future Disease Management","year":2011,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Disease; Dementia; Family history; Medicine; Population; Alzheimer's disease; Gerontology; Internal medicine","score_opus":0.05756196786905151,"score_gpt":0.3164721159376418,"score_spread":0.2589101480685903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974924861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6475979,0.08511592,0.0071522654,0.06621748,0.0025415074,0.0958555,0.025652954,0.0020212787,0.06784518],"genre_scores_gemma":[0.988044,0.001539419,0.0017216639,0.0024193265,0.00039755224,0.0037329474,0.0012088204,0.0001239013,0.00081233546],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9967833,0.00009150084,0.0005100333,0.0011567618,0.0007477757,0.0007105826],"domain_scores_gemma":[0.99476516,0.00017748949,0.00018422339,0.0014825551,0.00026893505,0.003121608],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000087287626,0.0005797142,0.0004338758,0.0003687863,0.00028438008,0.000043995267,0.00036779328,0.000033157998,0.00034526555],"category_scores_gemma":[0.00015767897,0.00050410733,0.0004730919,0.0005126494,0.00013117369,0.0001426559,0.00024013144,0.00013157833,0.00012764981],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02925887,0.07303213,0.3207811,0.0050994777,0.057590336,0.012117894,0.00059752446,0.00041603137,0.00007230217,0.3277998,0.12173217,0.051502354],"study_design_scores_gemma":[0.0064015896,0.00078855467,0.96391004,0.0002845122,0.020419555,0.000001395637,0.00008701274,0.00016400247,0.00037482005,0.0040927567,0.0029869443,0.0004888247],"about_ca_topic_score_codex":0.000009217303,"about_ca_topic_score_gemma":0.000004089893,"teacher_disagreement_score":0.64312893,"about_ca_system_score_codex":0.00007222238,"about_ca_system_score_gemma":0.00028980893,"threshold_uncertainty_score":0.9997411},"labels":[],"label_agreement":null},{"id":"W1980468738","doi":"10.2217/nmt.13.72","title":"Integrating Community Services into Primary Care: Improving the Quality of Dementia Care","year":2014,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alzheimer Society of Canada; St Joseph's Health Care; Lawson Health Research Institute; Centre for Family Medicine","funders":"","keywords":"General partnership; Dementia; Primary care; Nursing; Medicine; Quality (philosophy); Health care; Business; Public relations; Family medicine; Political science; Disease","score_opus":0.016965621901300094,"score_gpt":0.3077852713810352,"score_spread":0.2908196494797351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980468738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97466683,0.001017672,0.0031635435,0.00031578832,0.00011029996,0.0013418687,0.000026736125,0.00005479401,0.019302474],"genre_scores_gemma":[0.996431,0.000043780838,0.0007883062,0.0018887421,0.00007050976,0.00020501355,0.00039193884,0.000026672573,0.00015403512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967811,0.0013229505,0.00044047637,0.00036638475,0.00077925617,0.00030981327],"domain_scores_gemma":[0.9981582,0.00014267483,0.00018846574,0.0007887668,0.0005276966,0.0001941638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007244005,0.00024924966,0.00030422336,0.00011644155,0.00059804734,0.00007964834,0.00037851898,0.000027237451,0.00004315279],"category_scores_gemma":[0.00008010155,0.0001747283,0.00018621494,0.00024497785,0.00017544582,0.00011994553,0.0006678799,0.0003485529,0.00001069606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014606871,0.0013781814,0.5079954,0.031074364,0.0010917769,0.000041877203,0.021319525,0.00010441838,0.040949754,0.011656801,0.0002149234,0.38271227],"study_design_scores_gemma":[0.0020969813,0.0005313522,0.9518014,0.00027039007,0.0007858731,4.1566932e-7,0.030069305,0.00058554264,0.012236003,0.00017315637,0.0012069124,0.00024266969],"about_ca_topic_score_codex":0.00038249468,"about_ca_topic_score_gemma":0.00014950833,"teacher_disagreement_score":0.44380596,"about_ca_system_score_codex":0.00011392592,"about_ca_system_score_gemma":0.000070116206,"threshold_uncertainty_score":0.7125213},"labels":[],"label_agreement":null},{"id":"W2006577381","doi":"10.2217/nmt.14.39","title":"Diagnosing Motoric Cognitive Risk Syndrome to Predict Progression to Dementia","year":2014,"lang":"en","type":"editorial","venue":"Neurodegenerative Disease Management","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dementia; Neurology; Cognition; Gerontology; Cognitive decline; Population; Medicine; Psychology; Disease; Montreal Cognitive Assessment; Psychiatry; Cognitive impairment; Internal medicine","score_opus":0.01382001842113447,"score_gpt":0.3470559544398969,"score_spread":0.33323593601876245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006577381","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04488835,0.00078234787,0.013232138,0.0004497916,0.91621315,0.015897697,0.0040905788,0.0005574249,0.0038885025],"genre_scores_gemma":[0.17836656,0.0019570952,0.0018744363,0.003769068,0.7687978,0.025411583,0.008100333,0.0006044524,0.011118658],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910365,0.0026353216,0.0011522244,0.0020483944,0.0018558447,0.0012717273],"domain_scores_gemma":[0.9953497,0.0008911967,0.0008208109,0.0009643792,0.0006962694,0.0012776274],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00113041,0.00092963193,0.00092566526,0.00060443307,0.0015956081,0.00012152553,0.00068171404,0.00048812162,0.0000831756],"category_scores_gemma":[0.0014675359,0.0008820666,0.000310158,0.00057832844,0.000055102948,0.00018541879,0.0012862242,0.0015180971,0.0018037431],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005474055,0.00079375727,0.002966279,0.001419433,0.00048419338,0.00019967448,0.00034406345,0.000032659198,0.00002999705,0.00013428726,0.9868123,0.006235965],"study_design_scores_gemma":[0.0025837664,0.0008153325,0.17778748,0.005095644,0.0023669228,1.8107951e-7,0.00016132239,0.00021413362,0.0000035607802,0.00021292212,0.8096901,0.0010686232],"about_ca_topic_score_codex":0.000044641354,"about_ca_topic_score_gemma":0.000054119002,"teacher_disagreement_score":0.17712218,"about_ca_system_score_codex":0.0004432099,"about_ca_system_score_gemma":0.0002672542,"threshold_uncertainty_score":0.9997042},"labels":[],"label_agreement":null},{"id":"W2036362473","doi":"10.2217/nmt.12.63","title":"The Health and well-being of Alzheimer’s Patients Requires an Integration of Services Centered On the Patient","year":2013,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Interprofessional Education and Collaboration","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Psychology; Medicine","score_opus":0.031034936652022428,"score_gpt":0.36714771574522653,"score_spread":0.3361127790932041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036362473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865076,0.00013212934,0.000031905543,0.00791364,0.0005999258,0.0021506588,0.000016186445,0.000013093653,0.0026348513],"genre_scores_gemma":[0.9920006,0.00011770956,0.000058258483,0.0068992907,0.000037199592,0.00049317157,0.000106709485,0.000012492536,0.00027458838],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.997683,0.0010767094,0.0005191591,0.00021914848,0.00032137785,0.00018061107],"domain_scores_gemma":[0.9985119,0.00013606915,0.00047053356,0.00033494583,0.0004177215,0.00012884387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021102405,0.00012879219,0.00012600528,0.000064281994,0.0008170947,0.000024137218,0.00014674308,0.000021985968,0.00009643422],"category_scores_gemma":[0.000040277828,0.0000697166,0.000031535637,0.00014402035,0.000062885214,0.00016307963,0.00010647052,0.00012686168,0.000020674963],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024086412,0.0024119623,0.04324038,0.001092092,0.00036933637,9.950624e-7,0.102759235,0.00015838115,0.0014652009,0.6802778,0.05977265,0.10604329],"study_design_scores_gemma":[0.0015488431,0.0019444786,0.85420936,0.0015551926,0.00012479516,3.9683844e-8,0.113248646,0.008405222,0.002807537,0.0071724094,0.008616004,0.0003674709],"about_ca_topic_score_codex":0.00014086945,"about_ca_topic_score_gemma":0.000094736184,"teacher_disagreement_score":0.810969,"about_ca_system_score_codex":0.00003934775,"about_ca_system_score_gemma":0.00011068473,"threshold_uncertainty_score":0.62845147},"labels":[],"label_agreement":null},{"id":"W2047333481","doi":"10.2217/nmt.13.38","title":"Easing the Strain of Movement Disorders: From Translational and Clinical Science to Rehabilitation Strategies","year":2013,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Wilfrid Laurier University","funders":"","keywords":"Medal; Globe; Political science; Library science; Management; Media studies; Gerontology; Medicine; History; Sociology; Art history; Ophthalmology","score_opus":0.016807636923137297,"score_gpt":0.31425134537156146,"score_spread":0.29744370844842416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047333481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98053306,0.00009648635,0.0029433335,0.013398067,0.00016352865,0.0015205902,0.000045282723,0.000015869315,0.0012837609],"genre_scores_gemma":[0.9931262,0.000043306187,0.0052589225,0.0013073481,0.000056425455,0.00010276426,0.000017888635,0.000007921439,0.000079224155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986305,0.000120694975,0.00033026282,0.0003612631,0.00042554297,0.00013169456],"domain_scores_gemma":[0.9990834,0.00029564166,0.00005956877,0.00024134871,0.00013750154,0.00018251954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027714076,0.00010751334,0.00014236831,0.00012281747,0.000120579425,0.00007050502,0.00008513248,0.000014274869,0.00010249434],"category_scores_gemma":[0.00016082269,0.00007341416,0.00009284001,0.0002351538,0.00043158588,0.00020813162,0.000049679576,0.00006433676,0.000008668618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092235894,0.0023408125,0.542879,0.00053673785,0.00044998547,0.0000062229637,0.0058636265,0.007366479,0.026050875,0.15011667,0.0029187647,0.2605485],"study_design_scores_gemma":[0.00058481534,0.00027746925,0.9849229,0.000047609057,0.00007368776,3.2304605e-8,0.002609762,0.0030566358,0.00006719161,0.0080310535,0.0002588034,0.00007005527],"about_ca_topic_score_codex":0.000042688363,"about_ca_topic_score_gemma":0.000012648578,"teacher_disagreement_score":0.4420439,"about_ca_system_score_codex":0.000022930066,"about_ca_system_score_gemma":0.00008875161,"threshold_uncertainty_score":0.29937425},"labels":[],"label_agreement":null},{"id":"W2055299888","doi":"10.2217/nmt.12.37","title":"Management of Alzheimer’s Disease Using disease-modifying Drugs","year":2012,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Disease; Intensive care medicine; Medicine; Clinical Practice; Alzheimer's disease; Pathology; Family medicine","score_opus":0.05306711913838356,"score_gpt":0.34826797421715244,"score_spread":0.29520085507876886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055299888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97299945,0.00577986,0.0029824122,0.0008029163,0.00043519324,0.003397467,0.00014349933,0.00012763687,0.013331545],"genre_scores_gemma":[0.9945429,0.0005603313,0.0012762967,0.0008150739,0.00023294162,0.0003767932,0.00020141173,0.00008017361,0.0019140979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99611115,0.00024379669,0.0005316079,0.0007377841,0.0014277769,0.0009479075],"domain_scores_gemma":[0.99678797,0.000023971314,0.00016680067,0.0008263194,0.0001999005,0.0019950592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037401752,0.00045957885,0.0004011741,0.0003897591,0.0002615387,0.000060037524,0.0002277876,0.00002633467,0.00048413532],"category_scores_gemma":[0.000020420972,0.00042718623,0.00038534016,0.0005167565,0.00019098165,0.00036761162,0.0005611905,0.00016494012,0.00009770984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009438543,0.013936442,0.81057423,0.00942116,0.0063525382,0.005964845,0.0007335448,0.0014809226,0.0020726651,0.06831768,0.004574783,0.06713264],"study_design_scores_gemma":[0.0028794014,0.00009359955,0.9806091,0.0005508354,0.0058051697,0.0000014778198,0.0005030092,0.0037387174,0.0017068845,0.00022888249,0.0033848153,0.0004980638],"about_ca_topic_score_codex":0.0000048332454,"about_ca_topic_score_gemma":9.4338525e-8,"teacher_disagreement_score":0.1700349,"about_ca_system_score_codex":0.00012276815,"about_ca_system_score_gemma":0.000087641725,"threshold_uncertainty_score":0.99981797},"labels":[],"label_agreement":null},{"id":"W2113866317","doi":"10.2217/nmt.11.14","title":"Managing relapsing–remitting Multiple Sclerosis Following First Drug Failure","year":2011,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Health Sciences Centre","funders":"","keywords":"Glatiramer acetate; Multiple sclerosis; Relapsing remitting; Medicine; Intensive care medicine; Disease; Drug; First line; Immunology; Pharmacology; Internal medicine","score_opus":0.07019769101573509,"score_gpt":0.26761695616411535,"score_spread":0.19741926514838026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113866317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93555045,0.0011420337,0.002415734,0.009740478,0.00083446596,0.003528424,0.00005808505,0.0006757339,0.046054598],"genre_scores_gemma":[0.98784107,0.00073147006,0.0069192946,0.0014433701,0.000174865,0.00044244248,0.00005279805,0.00009779632,0.0022969085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654317,0.00017809156,0.0004689827,0.0010512718,0.0009511848,0.0008072775],"domain_scores_gemma":[0.99816376,0.000118628785,0.00012727018,0.0008494389,0.000140781,0.0006001207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037863545,0.00046654083,0.00046073445,0.00035616307,0.0008124494,0.000098767756,0.00031094544,0.000038819093,0.00020528564],"category_scores_gemma":[0.00037850995,0.00042924532,0.0004372958,0.0005173672,0.00013722182,0.0002771402,0.00069685944,0.0003241491,0.00008660844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037682443,0.0050001414,0.6988225,0.0046749995,0.0062592435,0.005584269,0.017258633,0.0014160663,0.019049918,0.007055961,0.17323342,0.05787659],"study_design_scores_gemma":[0.008207375,0.00021771701,0.93770325,0.0020713853,0.0013973666,0.0000033897745,0.006064014,0.013840415,0.011058634,0.00020044745,0.017950151,0.0012858525],"about_ca_topic_score_codex":0.00008385205,"about_ca_topic_score_gemma":0.00012362815,"teacher_disagreement_score":0.23888072,"about_ca_system_score_codex":0.00026119288,"about_ca_system_score_gemma":0.000033803277,"threshold_uncertainty_score":0.99981594},"labels":[],"label_agreement":null},{"id":"W2114005972","doi":"10.2217/nmt.13.6","title":"Neuropsychiatric Symptoms in Primary Progressive Aphasia: phenomenology, pathophysiology, and Approach to Assessment and Treatment","year":2013,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Neurobiology of Language and Bilingualism","field":"Neuroscience","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institutes of Health; Sidney R. Baer, Jr. Foundation","keywords":"Primary progressive aphasia; Phenomenology (philosophy); Pathophysiology; Aphasia; Psychology; Psychotherapist; Primary (astronomy); Medicine; Neuroscience; Disease; Philosophy; Dementia; Pathology; Epistemology; Physics","score_opus":0.015320660129572847,"score_gpt":0.26902449453877125,"score_spread":0.2537038344091984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114005972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913905,0.0004732544,0.000056212397,0.0012570227,0.00017521197,0.0027099098,0.000032215896,0.00007806146,0.0038275898],"genre_scores_gemma":[0.98839617,0.00040415968,0.001104044,0.008236299,0.00008669987,0.0014209833,0.000024696608,0.000033478776,0.00029344906],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99719197,0.00050160557,0.00029989838,0.0013654563,0.00015668418,0.00048441955],"domain_scores_gemma":[0.9990903,0.000083480525,0.00009657321,0.0004031385,0.000024687428,0.00030182977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006565831,0.0003884464,0.00034365666,0.0003216621,0.00018765482,0.00010104959,0.00021155164,0.000048193444,0.000017997074],"category_scores_gemma":[0.00002285776,0.0003050494,0.0000513684,0.00034865193,0.00026003175,0.00015532233,0.0003918119,0.0001561563,0.000019638941],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011400203,0.012760974,0.03826109,0.00077847624,0.00028324733,0.014386032,0.004855771,0.0014156952,0.48114815,0.033096198,0.002433641,0.4094407],"study_design_scores_gemma":[0.008209962,0.003981541,0.9727308,0.0000627351,0.00032295406,0.00023875241,0.00077104144,0.0033261222,0.002678301,0.0040613543,0.0017562226,0.0018601692],"about_ca_topic_score_codex":0.0000103010825,"about_ca_topic_score_gemma":0.0000012618184,"teacher_disagreement_score":0.93446976,"about_ca_system_score_codex":0.00007739158,"about_ca_system_score_gemma":0.00003259945,"threshold_uncertainty_score":0.99994016},"labels":[],"label_agreement":null},{"id":"W2118999156","doi":"10.2217/nmt.12.66","title":"‘Throwing a lifeline‘: the Role of First Link™ in Enhancing Support for Individuals With Dementia and Their Caregivers","year":2012,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alzheimer Society of Canada; St Joseph's Health Care; University of Waterloo; Lawson Health Research Institute; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"Ontario Ministry of Health and Long-Term Care; Alzheimer Society","keywords":"Dementia; Throwing; Link (geometry); Psychology; Medicine; Computer science; Engineering; Aeronautics; Disease; Computer network","score_opus":0.011537276199093404,"score_gpt":0.26428187841915346,"score_spread":0.25274460222006007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118999156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913087,0.001389199,0.0018493978,0.0012615545,0.0000499589,0.0022295567,0.00005490719,0.000016906524,0.001839801],"genre_scores_gemma":[0.9981092,0.000159523,0.00041338117,0.00042338262,0.00011561201,0.0004721189,0.00006058034,0.000023340057,0.00022283684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986792,0.00008924097,0.00023216176,0.0002887665,0.00030860025,0.00040198743],"domain_scores_gemma":[0.9993264,0.00007240519,0.0000743066,0.00021948553,0.000105736435,0.0002016377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043977532,0.00018660777,0.00021298199,0.00016070994,0.00014373625,0.00003049518,0.00009576749,0.000019388157,0.00005276957],"category_scores_gemma":[0.000039033952,0.000116988485,0.000071685754,0.00019866573,0.00010204156,0.00014366092,0.00015043115,0.00009393056,0.0000020666657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041037818,0.00044749363,0.9806017,0.0004415934,0.0005603567,0.000016778245,0.0024653566,0.000035413985,0.0015687236,0.0011109802,0.00023915399,0.012102023],"study_design_scores_gemma":[0.0045679756,0.00077191944,0.902785,0.00026300596,0.0009260775,0.0000034609234,0.009830669,0.0007871323,0.04940949,0.000121148005,0.030263945,0.00027016856],"about_ca_topic_score_codex":0.000010305058,"about_ca_topic_score_gemma":0.000029122366,"teacher_disagreement_score":0.07781674,"about_ca_system_score_codex":0.000028923805,"about_ca_system_score_gemma":0.000042689942,"threshold_uncertainty_score":0.4770652},"labels":[],"label_agreement":null},{"id":"W2126966802","doi":"10.2217/nmt.13.32","title":"Evidence-based Advances in the Treatment of Motor Features of Parkinson's Disease","year":2013,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dyskinesia; Intensive care medicine; Evidence-based medicine; Levodopa; Scientific evidence; Narcolepsy; Disease; Modafinil; Psychiatry; Parkinson's disease; Physical medicine and rehabilitation; Alternative medicine; Internal medicine","score_opus":0.028606913831032393,"score_gpt":0.2821197656993208,"score_spread":0.2535128518682884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126966802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96473074,0.02847762,0.00015476061,0.0018249718,0.00012770786,0.0036479325,0.0001719316,0.000029029105,0.0008353001],"genre_scores_gemma":[0.98928714,0.0073946756,0.00043626636,0.00075763697,0.000054919252,0.0016019663,0.000070460585,0.00002442681,0.0003725308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798244,0.00023920517,0.00034837774,0.00052482024,0.0006179801,0.00028719933],"domain_scores_gemma":[0.9985563,0.000112646805,0.00017285196,0.0007154406,0.0001178128,0.00032491915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007914911,0.00032625924,0.0003898457,0.0002307432,0.00006800417,0.000026574415,0.00019167055,0.000023255727,0.00015533365],"category_scores_gemma":[0.000043121436,0.00020273411,0.00030253947,0.00031923287,0.000113024646,0.00021749143,0.000029546476,0.00005024848,0.000016118896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016894976,0.0457866,0.5377702,0.0046703485,0.0013582255,0.004123055,0.0012828471,0.0045067156,0.0051005404,0.020235501,0.0036351974,0.35463575],"study_design_scores_gemma":[0.002762691,0.0010907947,0.9770632,0.0003810686,0.00073985115,4.2514938e-7,0.00014365824,0.0007701009,0.0031741997,0.00039209635,0.013313611,0.00016830354],"about_ca_topic_score_codex":0.00004052441,"about_ca_topic_score_gemma":0.000009320629,"teacher_disagreement_score":0.43929297,"about_ca_system_score_codex":0.00009671963,"about_ca_system_score_gemma":0.000093467344,"threshold_uncertainty_score":0.82672566},"labels":[],"label_agreement":null},{"id":"W2129350985","doi":"10.2217/nmt.11.23","title":"ABCA1, Apoe and apoA-I As Potential Therapeutic Targets for Treating Alzheimer’s Disease","year":2011,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Apolipoprotein E; ABCA1; Disease; Neuroprotection; Neuroscience; Transporter; Alzheimer's disease; Cholesterol; Pathogenesis; Medicine; Biology; Bioinformatics; Pharmacology; Immunology; Internal medicine; Genetics; Gene","score_opus":0.03952721411576197,"score_gpt":0.2810018794374431,"score_spread":0.24147466532168113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129350985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94411176,0.023561317,0.0077688764,0.0031299207,0.0015027716,0.0068286844,0.00027285938,0.0003568552,0.012466934],"genre_scores_gemma":[0.9908664,0.0003584317,0.0010372066,0.004321097,0.00046910977,0.00051906117,0.00014503031,0.00006449687,0.0022191494],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99826944,0.000087312386,0.00027610702,0.00068685017,0.00029666268,0.00038365336],"domain_scores_gemma":[0.99867636,0.000018518649,0.00009059366,0.0004304366,0.00008802135,0.00069606514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000103047336,0.00033465814,0.00030461393,0.00013808245,0.00022443247,0.000053383123,0.00010823992,0.00003062605,0.00017638423],"category_scores_gemma":[0.000025917616,0.00028085132,0.00019836881,0.00010369862,0.00009765115,0.00013144493,0.00011691787,0.000094396004,0.000028094435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033015493,0.008572308,0.030826408,0.00280064,0.005800827,0.0036062908,0.0066016763,0.00041854315,0.013681464,0.15366744,0.014051919,0.726957],"study_design_scores_gemma":[0.01190469,0.0007619794,0.90359384,0.00015584793,0.011258874,0.000013995746,0.0005561048,0.008523554,0.0050997096,0.004941157,0.05210128,0.0010889517],"about_ca_topic_score_codex":0.000008791864,"about_ca_topic_score_gemma":0.0000013865885,"teacher_disagreement_score":0.87276745,"about_ca_system_score_codex":0.000017060569,"about_ca_system_score_gemma":0.000042453878,"threshold_uncertainty_score":0.99996436},"labels":[],"label_agreement":null},{"id":"W2133551071","doi":"10.2217/nmt.14.5","title":"Depression Versus Dementia: Is This Construct Still relevant?","year":2014,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute; University of Toronto; St. Michael's Hospital; University of Calgary","funders":"","keywords":"Dementia; Prodrome; Depression (economics); Cognitive decline; Cognition; Late life depression; Cognitive impairment; Psychology; Etiology; Population; Clinical psychology; Psychiatry; Medicine; Neurodegeneration; Disease; Internal medicine","score_opus":0.050342392182383476,"score_gpt":0.31858143763878555,"score_spread":0.2682390454564021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133551071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005186708,0.9717967,0.00029450766,0.00012243958,0.0022704138,0.0023998644,0.00041085365,0.00027415037,0.022379212],"genre_scores_gemma":[0.00069115125,0.99382126,0.00016050925,0.0018469522,0.00023347726,0.00047706088,0.00011683066,0.00015157914,0.0025011543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944919,0.00095760956,0.0007746831,0.002156475,0.0009046233,0.0007147344],"domain_scores_gemma":[0.99725926,0.00036628896,0.00052921165,0.0013282794,0.00004672036,0.00047023452],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001389651,0.001003873,0.0012485202,0.00038809862,0.00040935667,0.00026150205,0.0010601905,0.00015926876,0.0011013543],"category_scores_gemma":[0.00028690932,0.0008318973,0.0008094409,0.0005932847,0.00027979075,0.00017486185,0.00080956175,0.00045492075,0.001214524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013784839,0.00022562935,0.0000022846814,0.008247816,0.00025150905,0.00030513405,0.00003709152,0.000010880139,0.000015023513,0.009864914,0.040401965,0.9404999],"study_design_scores_gemma":[0.0011238185,0.000067891546,0.000008206596,0.00161029,0.0014019615,0.0000028283566,0.000007710647,0.0001316901,0.0002261003,0.00012382373,0.99451584,0.0007798604],"about_ca_topic_score_codex":0.0000018569109,"about_ca_topic_score_gemma":0.0000014488113,"teacher_disagreement_score":0.95411384,"about_ca_system_score_codex":0.00009779487,"about_ca_system_score_gemma":0.00011646114,"threshold_uncertainty_score":0.99981177},"labels":[],"label_agreement":null},{"id":"W2406736647","doi":"10.2217/nmt-2016-0005","title":"Nondopaminergic Treatments for Parkinson’s Disease: Current and Future Prospects","year":2016,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Pharmacology; Dyskinesia; Dopaminergic; Levodopa; Medicine; Parkinson's disease; Antagonist; Monoamine oxidase; Dopamine; Neuroscience; Disease; Receptor; Chemistry; Psychology; Internal medicine; Biochemistry; Enzyme","score_opus":0.03581807469957903,"score_gpt":0.3291868301148216,"score_spread":0.29336875541524254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406736647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011615064,0.98750424,0.000046980684,0.0007888521,0.00065437885,0.008783164,0.0013899911,0.00010856818,0.0006076506],"genre_scores_gemma":[0.00010646354,0.9866436,0.000092358074,0.0004918386,0.00078333454,0.006684286,0.001145152,0.00013124708,0.0039216904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967407,0.00015153785,0.0005098792,0.0016249212,0.00041051072,0.00056242367],"domain_scores_gemma":[0.9979375,0.000063845044,0.00026003996,0.00072634337,0.00007213178,0.00094015826],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000047231253,0.0009933441,0.0014538706,0.00023139657,0.0002202446,0.0000753782,0.00016680094,0.00008480663,0.00007412773],"category_scores_gemma":[0.00002221732,0.0005823114,0.0007912377,0.00020391154,0.0001016576,0.0000720011,0.00020597623,0.0001647732,0.00006335367],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045006687,0.0014075808,0.0002152877,0.015618807,0.00093127385,0.00086613616,0.000004608722,1.9702306e-7,1.2367816e-7,0.0039119353,0.0049541914,0.9716398],"study_design_scores_gemma":[0.003009035,0.00040457596,0.0032468922,0.0030648182,0.009933236,0.0000023552404,0.000002074397,0.000009754119,3.296403e-7,0.0005788052,0.9792727,0.0004754161],"about_ca_topic_score_codex":2.558076e-7,"about_ca_topic_score_gemma":3.104647e-7,"teacher_disagreement_score":0.9743185,"about_ca_system_score_codex":0.00014309568,"about_ca_system_score_gemma":0.00011425756,"threshold_uncertainty_score":0.9996628},"labels":[],"label_agreement":null},{"id":"W2518401648","doi":"10.2217/nmt-2016-0028","title":"Elucidating the Link Between the Modifiable Risk Factors of Alzheimer’s Disease and Neuroinflammation","year":2016,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Neuroinflammation; Microglia; Disease; Medicine; Alzheimer's disease; Diabetes mellitus; Neuroscience; Immune system; Risk factor; Immunology; Psychology; Inflammation; Internal medicine; Endocrinology","score_opus":0.046299871767104685,"score_gpt":0.26424517864353203,"score_spread":0.21794530687642735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518401648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769889,0.00007707994,0.009158911,0.010834032,0.00033596327,0.001708783,0.00027192495,0.00014691964,0.00047747802],"genre_scores_gemma":[0.99794155,0.0004847149,0.00005283094,0.0005376041,0.00030506757,0.00013795342,0.000012031801,0.000048100177,0.00048011838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963808,0.0011488714,0.0005829951,0.0008123138,0.0007213947,0.00035358942],"domain_scores_gemma":[0.9975356,0.00068421144,0.00048481088,0.0009180559,0.000077699005,0.00029964422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003507947,0.0003558626,0.00022194922,0.00013786278,0.00091478165,0.00016963576,0.00049726316,0.000026021327,0.000062028565],"category_scores_gemma":[0.0007052,0.00017863573,0.00014396591,0.00035603298,0.00030072173,0.00039468778,0.00035563804,0.00017137546,0.000033495584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033923073,0.000118709024,0.006304164,0.00013043263,0.00014583918,0.000088435234,0.0006153224,0.01745386,0.7068861,0.20667323,0.0014323108,0.059812363],"study_design_scores_gemma":[0.00085623615,0.00009531909,0.06341295,0.00004150176,0.00055893854,9.661562e-7,0.000046603025,0.013731312,0.913322,0.003992986,0.0035460962,0.0003950977],"about_ca_topic_score_codex":0.0000053942135,"about_ca_topic_score_gemma":8.942593e-7,"teacher_disagreement_score":0.2064359,"about_ca_system_score_codex":0.000016445128,"about_ca_system_score_gemma":0.00003609151,"threshold_uncertainty_score":0.72845536},"labels":[],"label_agreement":null},{"id":"W2752267739","doi":"10.2217/nmt-2017-0015","title":"Health System Redesign Using Collective Impact: Implementation of the Behavioural Supports Ontario Initiative in Southwest Ontario","year":2017,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Stroke Network; Hamilton Health Sciences; St Joseph's Health Care; Lawson Health Research Institute","funders":"","keywords":"Neurocognitive; Process management; Mental health; Scale (ratio); Business; Healthcare system; Collective leadership; Theory of change; Public relations; Service (business); Nursing; Health care; Psychology; Knowledge management; Political science; Medicine; Cognition; Marketing; Computer science; Sociology; Psychiatry; Geography","score_opus":0.422591144028049,"score_gpt":0.5633648945292784,"score_spread":0.14077375050122942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752267739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882989,0.0000052056,0.000326485,0.0025739856,0.0007890978,0.005321657,0.0004732092,0.0000249951,0.0021864967],"genre_scores_gemma":[0.9952632,0.000002069652,0.00031113042,0.002386857,0.00005167203,0.0005821521,0.000033365468,0.000028640854,0.0013408683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943736,0.0019859686,0.0013408437,0.0006221175,0.00076346373,0.0009140158],"domain_scores_gemma":[0.99618787,0.00015860617,0.0019618198,0.0009859122,0.00029347735,0.00041233847],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0015716712,0.00031417183,0.0004824903,0.0002718843,0.0032130082,0.0000741871,0.00059788104,0.000049847327,0.0004835377],"category_scores_gemma":[0.00009840048,0.00025072187,0.00014397872,0.00031289126,0.00017228097,0.00048645315,0.0005156545,0.00046303062,0.000013744993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00009354533,0.000054591983,0.94041663,0.00017122993,0.00003177302,0.00002152335,0.056389757,0.00019812094,0.000024030862,0.0010047009,0.0014557946,0.00013831805],"study_design_scores_gemma":[0.0019289711,0.00011024013,0.98455334,0.0002512577,0.000058322057,7.6740014e-7,0.01243748,0.00009861312,0.000076975244,0.00007318245,0.00023157691,0.00017928139],"about_ca_topic_score_codex":0.7008668,"about_ca_topic_score_gemma":0.93698263,"teacher_disagreement_score":0.23611578,"about_ca_system_score_codex":0.010530998,"about_ca_system_score_gemma":0.011076667,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W2752322426","doi":"10.2217/nmt-2017-0014","title":"Treatment Gaps in Parkinson’s Disease Care in the Philippines","year":2017,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders; University of Alberta","funders":"","keywords":"Health care; Medicine; Government (linguistics); Disease; Developing country; Population; Epidemiology; Business; Economic growth; Environmental health; Economics","score_opus":0.07223312978937874,"score_gpt":0.35843260161348933,"score_spread":0.2861994718241106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752322426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074695697,0.9869468,0.0000029735363,0.0003860553,0.00036264907,0.0073318277,0.00083334686,0.00005555796,0.0033338068],"genre_scores_gemma":[0.016031219,0.97217304,0.00004136585,0.00037959684,0.00030320074,0.007356516,0.0020453637,0.00012312115,0.001546591],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954565,0.00069015456,0.0007592474,0.0016481156,0.0007327443,0.00071320025],"domain_scores_gemma":[0.9966089,0.0000642796,0.00036172246,0.002254461,0.000059974365,0.00065064355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001393194,0.0011971153,0.0018727907,0.0006925543,0.00032368954,0.00020312678,0.0006365338,0.00011131451,0.000073104675],"category_scores_gemma":[0.000054018285,0.00074805116,0.0010762126,0.00038632282,0.000103009406,0.000122059115,0.00022552247,0.00029825658,0.00013964962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004869313,0.0026952124,0.0016016356,0.015116387,0.00053854036,0.03561465,0.00028639444,0.000020037225,4.579747e-8,0.0010807446,0.00037100766,0.94218844],"study_design_scores_gemma":[0.002778332,0.00023859265,0.02177863,0.0055258903,0.005140809,0.000009525654,0.00011700302,0.000031174146,3.2500606e-7,0.00006988549,0.963778,0.0005318366],"about_ca_topic_score_codex":0.000036867095,"about_ca_topic_score_gemma":0.0001238721,"teacher_disagreement_score":0.963407,"about_ca_system_score_codex":0.0009550157,"about_ca_system_score_gemma":0.00053945446,"threshold_uncertainty_score":0.99949706},"labels":[],"label_agreement":null},{"id":"W2782023683","doi":"10.2217/nmt-2017-0054","title":"Advancing the Understanding of Progression in Multiple Sclerosis: An Interview With Shibeshih Belachew","year":2018,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Center for Neuroscience Research; National Institutes of Health; Children's National Hospital; Biogen","keywords":"Library science; Clinical neurology; Medicine; Medical education; Family medicine; Management; Psychology; Neuroscience","score_opus":0.1548569299515765,"score_gpt":0.3465572736736507,"score_spread":0.1917003437220742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782023683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98268116,0.00080372166,0.005078778,0.006090813,0.00010218963,0.003128148,0.000026061884,0.00007122817,0.0020179092],"genre_scores_gemma":[0.996927,0.00051454635,0.0012204292,0.00082574104,0.00008368116,0.00029964233,0.000018836965,0.0000319221,0.000078198056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783313,0.00036000778,0.00030086344,0.00048737493,0.00063600624,0.00038260632],"domain_scores_gemma":[0.9989162,0.00007717186,0.00010510031,0.0005439766,0.00014320633,0.00021431173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051373284,0.00021873681,0.00028553323,0.00018697976,0.0002463629,0.000038184495,0.0002027019,0.000019256755,0.0000506229],"category_scores_gemma":[0.00013198545,0.0001294094,0.000066882596,0.0004798682,0.00044814404,0.00017351659,0.00029207335,0.0001620088,0.0000039459283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018451028,0.011258309,0.5813444,0.008203752,0.0022566628,0.00079295266,0.022150125,0.002550519,0.065590665,0.018480618,0.010790016,0.25813094],"study_design_scores_gemma":[0.0059506022,0.0023511737,0.94483477,0.004482311,0.00031588972,0.0000014882148,0.008648299,0.019321565,0.012104752,0.00010787251,0.0014947951,0.0003864728],"about_ca_topic_score_codex":0.000013110027,"about_ca_topic_score_gemma":0.0004076709,"teacher_disagreement_score":0.36349034,"about_ca_system_score_codex":0.00018723053,"about_ca_system_score_gemma":0.00004609437,"threshold_uncertainty_score":0.5277162},"labels":[],"label_agreement":null},{"id":"W2901894875","doi":"10.2217/nmt-2018-0024","title":"Persons with Dementia and Care Partners’ Perspectives on Memory Clinics in Primary Care","year":2018,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Peter's Hospital; McMaster University; Centre for Family Medicine","funders":"","keywords":"Dementia; Primary care; Memory clinic; Psychology; Cognition; Nursing; Collaborative Care; Medicine; Cognitive impairment; Family medicine; Psychiatry; Disease","score_opus":0.01749310430209817,"score_gpt":0.3127171981982451,"score_spread":0.29522409389614696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901894875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9275116,0.0021293277,0.00008238651,0.00041648635,0.000060159062,0.0014946786,0.000038606355,0.00004610923,0.06822068],"genre_scores_gemma":[0.9962461,0.0003471853,0.00034587714,0.0012977567,0.00013982976,0.0002487982,0.0001267824,0.000036550708,0.001211109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978657,0.00016413025,0.00018582938,0.0008053174,0.0005827751,0.0003962582],"domain_scores_gemma":[0.99898106,0.000024773337,0.00004823585,0.00035469615,0.00027872866,0.00031250113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099277604,0.00027108987,0.00024030432,0.00027760284,0.00020753409,0.00006636624,0.000095344185,0.000029173225,0.00011458256],"category_scores_gemma":[0.000016331356,0.00021932727,0.00007228197,0.00025998557,0.00031555103,0.00009749012,0.0001575074,0.00018626539,0.000031162293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009479513,0.0023056888,0.8694449,0.002535587,0.0011334344,0.0025902868,0.04402117,0.00005296662,0.00043883704,0.0034322217,0.002321452,0.06224394],"study_design_scores_gemma":[0.0049107694,0.0027434074,0.91769487,0.00027401224,0.0005704212,0.0000023971163,0.07018678,0.000092615155,0.00083307136,0.00000998617,0.0023878473,0.00029385058],"about_ca_topic_score_codex":0.0000050928334,"about_ca_topic_score_gemma":0.000027709975,"teacher_disagreement_score":0.06873454,"about_ca_system_score_codex":0.00017275181,"about_ca_system_score_gemma":0.00011592606,"threshold_uncertainty_score":0.89439064},"labels":[],"label_agreement":null},{"id":"W2910229208","doi":"10.2217/nmt-2018-0031","title":"Person-Centered Risk Assessment Framework: Assessing and Managing Risk in Older Adults Living With Dementia","year":2019,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Peter's Hospital; McMaster University; Centre for Family Medicine","funders":"","keywords":"Dementia; Risk assessment; Health care; Nursing; Medicine; Psychology; Disease","score_opus":0.01243781710770302,"score_gpt":0.2893636226231173,"score_spread":0.2769258055154143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910229208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759471,0.000503919,0.012410407,0.00064779783,0.00011663667,0.0023695007,0.000020957264,0.00006454388,0.007919135],"genre_scores_gemma":[0.9927964,0.00086803373,0.0046717785,0.0006404259,0.00005474711,0.00024987137,0.00003846265,0.000058404574,0.0006218566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673754,0.00047246186,0.00029652548,0.0010455529,0.0008078851,0.0006400366],"domain_scores_gemma":[0.99872917,0.00012575486,0.00017895947,0.00046994793,0.00013186011,0.00036430696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049623335,0.00037784333,0.000355449,0.00040114243,0.0002350596,0.00027492532,0.00012438602,0.0000419396,0.00062072504],"category_scores_gemma":[0.000053612384,0.0003189992,0.000096546326,0.00035588094,0.000081038415,0.00032060558,0.00027534066,0.0005360187,0.000039851446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033932467,0.000826674,0.97326344,0.00058513856,0.00041808892,0.00035507153,0.0004188169,0.00009127977,0.000027780266,0.00051097997,0.00010627221,0.023057142],"study_design_scores_gemma":[0.003929305,0.00034879276,0.9772176,0.0019400874,0.0006956837,0.0000029611358,0.0033314202,0.012005109,0.000037047095,0.000045946555,0.00013189898,0.00031411936],"about_ca_topic_score_codex":0.000042200878,"about_ca_topic_score_gemma":0.000012151154,"teacher_disagreement_score":0.022743022,"about_ca_system_score_codex":0.00012543538,"about_ca_system_score_gemma":0.000055465294,"threshold_uncertainty_score":0.9999262},"labels":[],"label_agreement":null},{"id":"W2978087496","doi":"10.2217/nmt-2019-0017","title":"What is Test Accuracy? Comparing Unitary Accuracy Metrics for Cognitive Screening Instruments","year":2019,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Receiver operating characteristic; Metric (unit); Dementia; Test (biology); Cognition; Cognitive impairment; Raw score; Statistics; Measure (data warehouse); Psychology; Computer science; Medicine; Mathematics; Data mining; Raw data; Psychiatry; Engineering","score_opus":0.04453971085852782,"score_gpt":0.3395502077307218,"score_spread":0.295010496872194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978087496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805527,0.0005755581,0.004182224,0.001611587,0.0004952426,0.0061496557,0.00017455615,0.000106686006,0.006151797],"genre_scores_gemma":[0.9840777,0.0009814578,0.0007363696,0.0063323844,0.00013805288,0.00064968853,0.00075109967,0.00007125726,0.006261995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967007,0.00013052457,0.00044856346,0.0009807427,0.0010118826,0.0007275843],"domain_scores_gemma":[0.9974117,0.00079969823,0.00017663384,0.00047862055,0.000585789,0.0005475494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032778006,0.00042961183,0.00045348713,0.00055874133,0.00029556957,0.00039697668,0.00026534146,0.000046302932,0.0005369231],"category_scores_gemma":[0.000629341,0.00040496187,0.00027591226,0.0007702392,0.00008794361,0.0010170335,0.00049191783,0.00026017005,0.00025988775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027843274,0.0022413558,0.79384184,0.0014136117,0.0012738357,0.00025998487,0.00034956756,0.000054340504,0.0010787296,0.000841678,0.004543142,0.19131759],"study_design_scores_gemma":[0.01781835,0.0018301646,0.90136224,0.0015095281,0.0019754604,0.000006930112,0.0051855682,0.030673215,0.018938132,0.00025086282,0.019479418,0.0009701344],"about_ca_topic_score_codex":0.0000063321695,"about_ca_topic_score_gemma":0.0000015683361,"teacher_disagreement_score":0.19034745,"about_ca_system_score_codex":0.00010176854,"about_ca_system_score_gemma":0.000091890404,"threshold_uncertainty_score":0.9998402},"labels":[],"label_agreement":null},{"id":"W2978638447","doi":"10.2217/nmt-2019-0015","title":"Is Huntington’s Disease On the Threshold of a New Era in Treatment?","year":2019,"lang":"en","type":"editorial","venue":"Neurodegenerative Disease Management","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"MEDLINE; Disease; Huntington's disease; Medicine; Family medicine; Library science; Psychiatry; Internal medicine; Biology; Computer science","score_opus":0.03609737167322812,"score_gpt":0.28901521388215906,"score_spread":0.25291784220893093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978638447","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46661162,0.0008081021,0.000036325433,0.00634623,0.49534532,0.011000418,0.007321898,0.00024016073,0.012289917],"genre_scores_gemma":[0.69986194,0.0038303467,0.00005945919,0.010694202,0.21563399,0.0023999538,0.00071049365,0.0006996171,0.06610997],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9915872,0.0009120318,0.0010109465,0.002991111,0.0025289715,0.0009697014],"domain_scores_gemma":[0.9942574,0.0012857799,0.0006513305,0.0028729609,0.00016465789,0.00076790096],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00019496669,0.0014085097,0.0009912102,0.0006381127,0.00026605598,0.00028858628,0.0016885049,0.0001552208,0.00049060135],"category_scores_gemma":[0.0013540159,0.0010508613,0.00076069497,0.0008922613,0.0002939414,0.00016916989,0.00063889974,0.0007441677,0.00043196508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013305638,0.0015374393,0.0005397675,0.00036221792,0.000102352904,0.0002899391,0.0002560846,0.005508977,0.0017064931,0.0062471847,0.9815043,0.0006146474],"study_design_scores_gemma":[0.006568879,0.0013567668,0.007876843,0.0010292458,0.0014896797,2.3513722e-7,0.000113434515,0.0022313243,0.21620692,0.0024564094,0.75794894,0.0027213523],"about_ca_topic_score_codex":0.00004090147,"about_ca_topic_score_gemma":0.000019385005,"teacher_disagreement_score":0.27971134,"about_ca_system_score_codex":0.00035006844,"about_ca_system_score_gemma":0.0011147631,"threshold_uncertainty_score":0.9998665},"labels":[],"label_agreement":null},{"id":"W3004605337","doi":"10.2217/nmt-2019-0021","title":"Generalized Chorea Associated With Subcortical Leukoaraiosis of Binswanger Type: A Case Report","year":2020,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Cerebrovascular and genetic disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Leukoaraiosis; Parkinsonism; Chorea; Hyperintensity; Choreiform movement; Psychology; White matter; Movement disorders; Dementia; Medicine; Magnetic resonance imaging; Cardiology; Neuroscience; Disease; Physical medicine and rehabilitation; Pathology; Radiology; Parkinson's disease; Dyskinesia","score_opus":0.02534283383478469,"score_gpt":0.2595627934979508,"score_spread":0.2342199596631661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004605337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921808,0.0003258342,0.0008154028,0.0022657604,0.00006911902,0.0008927282,0.00002365494,0.00007458729,0.0033521024],"genre_scores_gemma":[0.9957534,0.00007989715,0.00044014482,0.002596873,0.000057263696,0.000062298786,0.00022228797,0.00004454021,0.00074328267],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9982344,0.00010357907,0.0003494815,0.0005594886,0.0005014536,0.00025161536],"domain_scores_gemma":[0.99875915,0.000016908356,0.000113546215,0.00043403654,0.00021318388,0.00046320388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000873319,0.00023884345,0.0003842941,0.00007927336,0.00006546258,0.000020057505,0.00007601157,0.000034865807,0.0002730736],"category_scores_gemma":[0.00017670724,0.000191499,0.00019280906,0.0005902812,0.00011442432,0.00003645506,0.000087802866,0.00010249375,0.000014442785],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0118561685,0.006695001,0.17273247,0.002114476,0.011506196,0.6919682,0.0021850509,0.0073239603,0.007872946,0.00877251,0.060565352,0.016407633],"study_design_scores_gemma":[0.038147807,0.0059550176,0.85932636,0.0004950179,0.018246528,0.0034531052,0.0014673664,0.027971549,0.018981704,0.00014004455,0.023227748,0.0025877508],"about_ca_topic_score_codex":0.000020228848,"about_ca_topic_score_gemma":0.000020384172,"teacher_disagreement_score":0.6885151,"about_ca_system_score_codex":0.000032712516,"about_ca_system_score_gemma":0.00009559273,"threshold_uncertainty_score":0.78091025},"labels":[],"label_agreement":null},{"id":"W3036437646","doi":"10.2217/nmt-2019-0030","title":"Evaluation of Antecedent Behaviors of dementia-related Wandering in Community and Facility Settings","year":2020,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Antecedent (behavioral psychology); Dementia; Psychology; Medicine; Psychotherapist; Disease; Internal medicine","score_opus":0.045070280100665695,"score_gpt":0.3280030471940711,"score_spread":0.28293276709340537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036437646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639326,0.00029152297,0.00017915398,0.0006330838,0.00001846106,0.0012972815,0.000041420368,0.000013553676,0.0011322798],"genre_scores_gemma":[0.99951756,0.00008118437,0.000048388032,0.00017565531,0.0000037746984,0.00007774739,0.0000713085,0.000007216989,0.000017155324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976683,0.00067520776,0.00037282452,0.00024936636,0.0008759289,0.00015836839],"domain_scores_gemma":[0.9992124,0.000026908749,0.000098964694,0.00018984711,0.00030450043,0.00016739384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011287096,0.00012725336,0.00022669871,0.00012734791,0.00006119147,0.000010237531,0.00007737177,0.000019199235,0.00014838479],"category_scores_gemma":[0.00017354554,0.00012214576,0.00006211638,0.00026761106,0.000109449815,0.00007194688,0.00022309557,0.00017087547,0.0000019659972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077305286,0.0020504838,0.89485663,0.001916917,0.0005403382,0.00006625217,0.0031500948,0.00054418517,0.05180713,0.0002204726,0.00011293806,0.043961488],"study_design_scores_gemma":[0.0033338156,0.0003997557,0.9625039,0.000111919726,0.0010560286,3.904261e-7,0.0015691633,0.0066726403,0.024173254,0.00006730391,0.000021969914,0.0000898318],"about_ca_topic_score_codex":0.000026149004,"about_ca_topic_score_gemma":0.000008465459,"teacher_disagreement_score":0.06764728,"about_ca_system_score_codex":0.000041714015,"about_ca_system_score_gemma":0.0000563048,"threshold_uncertainty_score":0.49809596},"labels":[],"label_agreement":null},{"id":"W3163517945","doi":"10.2217/nmt-2021-0005","title":"Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society of Canada; National Multiple Sclerosis Society","keywords":"Fingolimod; Medicine; Multiple sclerosis; Sphingosine-1-phosphate receptor; Tolerability; Receptor; Clinical trial; Bioinformatics; Internal medicine; Adverse effect; Sphingosine-1-phosphate; Immunology; Sphingosine; Biology","score_opus":0.03393061890345375,"score_gpt":0.2532120185054075,"score_spread":0.21928139960195372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163517945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748436,0.0060553523,0.017852696,0.00012179356,0.00022928414,0.0005267423,0.00014116436,0.000004805655,0.00022452913],"genre_scores_gemma":[0.99508643,0.0029125484,0.0010585425,0.00013661961,0.0001229393,0.0001444477,0.00012641001,0.000017746599,0.00039428676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992245,0.0000421746,0.00020060594,0.00027919226,0.00011522195,0.00013833138],"domain_scores_gemma":[0.9993271,0.000031037125,0.00009029077,0.00038007819,0.00011939285,0.000052093877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061502345,0.00012389963,0.00014583595,0.000024010662,0.000096287644,0.000012684377,0.00010033918,0.000021466169,0.000008496998],"category_scores_gemma":[0.000042117666,0.00008748215,0.00020742812,0.0000820962,0.000046293695,0.0000033279898,0.000056992132,0.000013531661,3.7589362e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004970518,0.0006664064,0.0018056799,0.00011979958,0.00039589088,0.0000042720217,0.0001762005,0.005511201,0.9701377,0.0047586397,0.00043333,0.015493796],"study_design_scores_gemma":[0.001691561,0.00021311172,0.009906327,0.000022439115,0.0002824339,2.386533e-7,0.00022681402,0.0016134103,0.96834654,0.000087124645,0.017497139,0.000112863694],"about_ca_topic_score_codex":0.0000031099337,"about_ca_topic_score_gemma":0.000008638151,"teacher_disagreement_score":0.020242827,"about_ca_system_score_codex":0.000007606601,"about_ca_system_score_gemma":0.0000305503,"threshold_uncertainty_score":0.35674185},"labels":[],"label_agreement":null},{"id":"W3217773060","doi":"10.2217/nmt-2021-0042","title":"MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis in a Phase IIb/III Study: COMBAT-ALS Study Design","year":2021,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Amyotrophic lateral sclerosis; Tolerability; Medicine; Neuroprotection; Riluzole; Quality of life (healthcare); Placebo; Clinical trial; Context (archaeology); Disease; Pharmacology; Internal medicine; Oncology; Adverse effect; Pathology","score_opus":0.08541449983593444,"score_gpt":0.3447099443251491,"score_spread":0.2592954444892147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217773060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98984647,0.0002805522,0.00019665677,0.0024390079,0.0002016978,0.0066433656,0.000036057565,0.00009073261,0.00026546553],"genre_scores_gemma":[0.99439204,0.00017296018,0.0001800584,0.0016921817,0.000069853115,0.001699876,0.00008371278,0.000095741314,0.0016135544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928471,0.0020991713,0.0010414846,0.0016340419,0.001415642,0.000962604],"domain_scores_gemma":[0.99779207,0.00009964932,0.00012978281,0.0011497552,0.00022316244,0.0006055788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008563447,0.00057996425,0.0009346566,0.000668214,0.00018982733,0.00022670854,0.00037682397,0.000057857225,0.00058828987],"category_scores_gemma":[0.00013751793,0.0005356539,0.00018676135,0.0017542612,0.0001179903,0.00025407106,0.0007652064,0.0005932441,0.00010209762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014811172,0.1349536,0.67151636,0.0005223994,0.0017793679,0.08277002,0.008172904,0.021903364,0.03713307,0.0007050464,0.0075236885,0.018209035],"study_design_scores_gemma":[0.03458735,0.0028610446,0.9542092,0.00023771924,0.00026934646,0.000003987875,0.0014540255,0.0051206844,0.000499974,0.0000788036,0.00018263022,0.0004951975],"about_ca_topic_score_codex":0.00011552706,"about_ca_topic_score_gemma":0.00018300324,"teacher_disagreement_score":0.2826929,"about_ca_system_score_codex":0.00048086143,"about_ca_system_score_gemma":0.00021214489,"threshold_uncertainty_score":0.9997095},"labels":[],"label_agreement":null},{"id":"W4206167951","doi":"10.2217/nmt-2021-0041","title":"Side Effects That Occurred Early in People With Multiple Sclerosis During the First Year of Treatment With Cladribine Tablets: A Plain Language Summary","year":2022,"lang":"en","type":"letter","venue":"Neurodegenerative Disease Management","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Placebo; Multiple sclerosis; Side effect (computer science); Dosing; Internal medicine; Alternative medicine; Psychiatry; Pathology","score_opus":0.016150902755551755,"score_gpt":0.2300972813157672,"score_spread":0.21394637856021545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206167951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680486,0.0011159938,0.000019934514,0.022743972,0.00011227271,0.0064639836,0.0005927076,0.00008263823,0.0008199348],"genre_scores_gemma":[0.95863587,0.00067491183,0.0001301772,0.02707454,0.0004665899,0.004618664,0.0014007237,0.00026487582,0.006733623],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9961307,0.00036694747,0.0003548443,0.0010639868,0.0013258185,0.0007577253],"domain_scores_gemma":[0.99780923,0.00037715302,0.00022396035,0.0013505523,0.0000617975,0.00017732964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001392987,0.0006557889,0.00080670905,0.000429805,0.00023135217,0.00007229705,0.00039770888,0.00009890992,0.00012989325],"category_scores_gemma":[0.00003324978,0.00040731567,0.00019414003,0.00070222805,0.00018917175,0.000090498885,0.00042612068,0.000788151,0.00001204077],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06508616,0.006120489,0.26894084,0.046822254,0.0109562455,0.17559803,0.015906494,0.022521377,0.0014340905,0.00009378581,0.3838778,0.0026424436],"study_design_scores_gemma":[0.20471908,0.014167338,0.5906793,0.008780238,0.0060406574,0.00013135828,0.0030917781,0.008746485,0.008529458,0.0000062503163,0.15187334,0.0032347513],"about_ca_topic_score_codex":0.0017681491,"about_ca_topic_score_gemma":0.0015632018,"teacher_disagreement_score":0.32173845,"about_ca_system_score_codex":0.008983137,"about_ca_system_score_gemma":0.0011172753,"threshold_uncertainty_score":0.9998379},"labels":[],"label_agreement":null},{"id":"W4225964837","doi":"10.2217/nmt-2021-0053","title":"Recruitment of Participants for Dementia Research: Interprofessional Perspectives From Primary care-based Memory Clinics","year":2022,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Family Medicine; Research Institute for Aging; McMaster University; University of Waterloo","funders":"","keywords":"Dementia; Primary care; Memory clinic; Psychology; Medicine; Nursing; Gerontology; Family medicine; Disease","score_opus":0.6474344058802497,"score_gpt":0.5855558567545249,"score_spread":0.06187854912572477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225964837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.968353,0.0057814512,0.0018331867,0.007925451,0.0009822886,0.009045166,0.0014288145,0.00007697667,0.004573675],"genre_scores_gemma":[0.985961,0.00026653,0.003949869,0.0020041675,0.00017481727,0.005357292,0.00060008303,0.00005723341,0.0016290064],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9936564,0.0013835838,0.00071131403,0.0010327616,0.0026308517,0.00058508717],"domain_scores_gemma":[0.9943403,0.003114222,0.00017645532,0.00096537994,0.00095461775,0.00044904338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033184,0.00021482211,0.00041450848,0.00031509405,0.00056980783,0.000027276721,0.0004926135,0.00006190007,0.00051701535],"category_scores_gemma":[0.0015649279,0.00020193035,0.00032438783,0.0003740768,0.0004368495,0.00004831645,0.0013337105,0.001197891,0.000010847493],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2378388,0.050784208,0.10090245,0.02333379,0.010936716,0.0022551585,0.03308902,0.021400005,0.026729845,0.33489323,0.03863716,0.11919962],"study_design_scores_gemma":[0.05668927,0.02879909,0.50145125,0.0046050656,0.007047932,0.0000011443075,0.17846829,0.026833054,0.03960724,0.09767555,0.05612964,0.0026924615],"about_ca_topic_score_codex":0.000017285152,"about_ca_topic_score_gemma":0.000016928125,"teacher_disagreement_score":0.40054882,"about_ca_system_score_codex":0.0005884071,"about_ca_system_score_gemma":0.0012616948,"threshold_uncertainty_score":0.82344806},"labels":[],"label_agreement":null},{"id":"W4241021086","doi":"10.2217/nmt.12.67","title":"Journal Watch: Our Panel of Experts Highlight the Most Important Research Articles Across the Spectrum of Topics Relevant to the Field of Neurodegenerative Disease Management","year":2012,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Field (mathematics); Disease; Broad spectrum; Data science; Medicine; Computer science; Pathology","score_opus":0.057572695240666404,"score_gpt":0.3531565859360407,"score_spread":0.29558389069537433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241021086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8876442,0.0018561565,0.00051668717,0.10628175,0.0005931599,0.00252162,0.00019676158,0.000018096795,0.0003715705],"genre_scores_gemma":[0.9932744,0.0013385566,0.0001708364,0.0029455305,0.0004045467,0.00033660387,0.00001971487,0.000042690805,0.0014671525],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9957391,0.00068414584,0.00080214074,0.00048880186,0.0015139147,0.0007718749],"domain_scores_gemma":[0.9971325,0.00015916057,0.00034704895,0.0013584147,0.00036478162,0.00063811714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010637803,0.0003654215,0.00041770766,0.00013423775,0.0006595066,0.00007207316,0.0006412964,0.000034320252,0.00006298792],"category_scores_gemma":[0.00021259868,0.00017914422,0.00029788652,0.00077460095,0.00015116559,0.0001274739,0.00068910554,0.00027237769,0.000011190366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025791753,0.027536336,0.15978096,0.003787664,0.010964867,0.0057812324,0.045996502,0.0073031774,0.024326008,0.2659175,0.34856305,0.074250944],"study_design_scores_gemma":[0.0052527427,0.0017462902,0.7112363,0.00063096447,0.0032648575,0.000025167064,0.018309833,0.0018231411,0.15695128,0.002686327,0.097301856,0.0007712724],"about_ca_topic_score_codex":0.000028661978,"about_ca_topic_score_gemma":0.000026728549,"teacher_disagreement_score":0.5514553,"about_ca_system_score_codex":0.00009902669,"about_ca_system_score_gemma":0.00009195358,"threshold_uncertainty_score":0.73052895},"labels":[],"label_agreement":null},{"id":"W4280536183","doi":"10.2217/nmt-2021-0055","title":"Glutamate Modulation for the Treatment of Levodopa Induced Dyskinesia: A Brief Review of the Drugs Tested in the Clinic","year":2022,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal; Montreal Neurological Institute and Hospital","funders":"","keywords":"Dyskinesia; Levodopa; Glutamate receptor; Pharmacology; Medicine; Internal medicine; Disease; Parkinson's disease","score_opus":0.20330965741343715,"score_gpt":0.43184195866469227,"score_spread":0.22853230125125512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280536183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003999702,0.97229326,0.000008671095,0.0023723566,0.0008683118,0.019599847,0.00048689052,0.000024857824,0.00034610895],"genre_scores_gemma":[0.004781225,0.985965,0.000002263443,0.003052799,0.000069577654,0.005438588,0.000013782115,0.00005012117,0.00062663475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99260604,0.0038613179,0.0010638819,0.0010079088,0.0010369949,0.00042382797],"domain_scores_gemma":[0.99490815,0.0027433438,0.00085502176,0.001363849,0.000058463975,0.000071173614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008870308,0.0004792637,0.0009847005,0.00022162395,0.0004910784,0.00004556591,0.001966274,0.000039883536,0.00009476296],"category_scores_gemma":[0.0005600712,0.00022658752,0.0008627655,0.0020807083,0.00032938799,0.00009449803,0.00040986744,0.00035472194,0.0000071186473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002713962,0.0037917455,0.000015472804,0.061471246,0.00013861337,0.00017431389,0.000501366,0.000278045,0.0014474429,0.0018536156,0.0035310637,0.92652565],"study_design_scores_gemma":[0.0008367799,0.0005575931,0.0002242048,0.0028550848,0.0014562464,0.0000062621293,0.000030074614,0.00065617496,0.0012624783,0.000033995973,0.99182236,0.0002587154],"about_ca_topic_score_codex":0.0000042759066,"about_ca_topic_score_gemma":0.0000015466861,"teacher_disagreement_score":0.9882913,"about_ca_system_score_codex":0.00012651959,"about_ca_system_score_gemma":0.00025879548,"threshold_uncertainty_score":0.9239971},"labels":[],"label_agreement":null},{"id":"W4286698798","doi":"10.2217/nmt-2022-0013","title":"The AT(N) System for Describing Biological Changes in Alzheimer’s Disease: A Plain Language Summary","year":2022,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Biological Research and Disease Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Disease; Dementia; Neurodegeneration; Neuroscience; Neurology; Alzheimer's disease; Medicine; Psychology; Pathology","score_opus":0.052728695708741675,"score_gpt":0.2915170587720517,"score_spread":0.23878836306331003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286698798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9321332,0.056202985,0.00028235704,0.0035853432,0.0004032808,0.0035333945,0.0020596457,0.00007782606,0.0017219541],"genre_scores_gemma":[0.99232584,0.00096057495,0.00003804858,0.0008682973,0.00014981037,0.004096096,0.00076876784,0.000019871331,0.00077268895],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794203,0.0004641952,0.00017707559,0.0006422036,0.0002615129,0.000512972],"domain_scores_gemma":[0.9991859,0.000076149736,0.000056256173,0.00037173444,0.000037393504,0.00027255822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036723082,0.0002129769,0.0001436642,0.000051792475,0.0010059231,0.000041955045,0.0003695574,0.000023189781,0.000018468569],"category_scores_gemma":[0.00014997674,0.0001468455,0.00014230612,0.00013745556,0.00013919176,0.0000028309707,0.0013588408,0.000091406626,0.0000036878448],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08871643,0.0045986506,0.09756234,0.001313883,0.0038279512,0.0050705452,0.0008309602,0.010715426,0.21825723,0.11355767,0.31891927,0.13662964],"study_design_scores_gemma":[0.008649246,0.0033658035,0.17189728,0.00013410588,0.00064242387,0.000006374299,0.01230993,0.004815384,0.022110645,0.0006198015,0.7729547,0.0024942975],"about_ca_topic_score_codex":0.0000045912066,"about_ca_topic_score_gemma":0.00007590657,"teacher_disagreement_score":0.45403546,"about_ca_system_score_codex":0.00008459302,"about_ca_system_score_gemma":0.00003960934,"threshold_uncertainty_score":0.773685},"labels":[],"label_agreement":null},{"id":"W4368360153","doi":"10.2217/nmt-2022-0039","title":"5-HT <sub>1A</sub> Agonists for levodopa-induced Dyskinesia in Parkinson’s Disease","year":2023,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Dyskinesia; Levodopa; Medicine; Parkinson's disease; Disease; Adverse effect; Clinical trial; Pharmacology; Internal medicine","score_opus":0.08036623754658324,"score_gpt":0.34309356382898115,"score_spread":0.2627273262823979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368360153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005024328,0.9725172,0.00023401191,0.00038559863,0.0013577862,0.016615964,0.002854674,0.0005228729,0.00048760054],"genre_scores_gemma":[0.0072299032,0.97027457,0.00018591929,0.00055639405,0.00060744147,0.013917003,0.0048221345,0.00053649547,0.0018701438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933076,0.00045814697,0.0012877159,0.0027009654,0.0010025017,0.0012431081],"domain_scores_gemma":[0.9957513,0.00016063385,0.000535206,0.0016277827,0.0001621343,0.0017628933],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0003130682,0.001650337,0.0026939046,0.0012174823,0.00031659481,0.00018613353,0.00051031756,0.00021532191,0.000039393934],"category_scores_gemma":[0.00016255086,0.0014599521,0.0018081901,0.0011771978,0.000076410055,0.00015914631,0.0004252172,0.00041817804,0.00048430654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002241837,0.004566998,0.00033140794,0.09847913,0.0034856913,0.0259557,0.000055370816,0.00010138878,0.000030172065,0.0047358964,0.009990196,0.8500262],"study_design_scores_gemma":[0.0041988655,0.00031265823,0.009365429,0.011346057,0.01226508,0.000006933118,0.000019645777,0.00053426705,0.00003954675,0.00036242022,0.9601464,0.0014026718],"about_ca_topic_score_codex":0.000008193692,"about_ca_topic_score_gemma":0.000024522886,"teacher_disagreement_score":0.9501562,"about_ca_system_score_codex":0.00081249856,"about_ca_system_score_gemma":0.00076052063,"threshold_uncertainty_score":0.9996244},"labels":[],"label_agreement":null},{"id":"W4379768482","doi":"10.2217/nmt-2023-0005","title":"A Plain Language Summary On the Effectiveness of Cladribine Tablets Compared With Other Oral Treatments for Multiple Sclerosis: Results From the Msbase Registry","year":2023,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Multiple sclerosis; Medicine; Dermatology; Medical physics; Natural language processing; Internal medicine; Computer science; Immunology","score_opus":0.05009979747776734,"score_gpt":0.28861253366580564,"score_spread":0.2385127361880383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379768482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879217,0.00008924454,0.00061543594,0.002006941,0.00007732404,0.0043745013,0.0039701476,0.00009103014,0.00085368723],"genre_scores_gemma":[0.994002,0.000034003442,0.00020241774,0.001065173,0.000097519245,0.0013750129,0.0014292634,0.00006451013,0.0017300872],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99740994,0.0006836805,0.00026826985,0.00061866647,0.00064518093,0.0003742359],"domain_scores_gemma":[0.9960191,0.0025600158,0.00012566395,0.0010201652,0.00011164357,0.00016338276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006006843,0.00029021146,0.00033513608,0.00008971824,0.00022463693,0.000041778352,0.00029636902,0.000033351913,0.000018323382],"category_scores_gemma":[0.0004816842,0.00014668575,0.0001293444,0.0004733087,0.00019984443,0.000043293134,0.0001626914,0.0001322336,0.000027131438],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46872061,0.0071710297,0.03497767,0.0023515313,0.011615618,0.0035009717,0.0040522115,0.037841108,0.10053527,0.006741248,0.31643564,0.0060570855],"study_design_scores_gemma":[0.07461656,0.0022221452,0.77482057,0.003569722,0.0025155444,0.0000025827314,0.0030739068,0.06961993,0.06421663,0.00015486732,0.004509964,0.0006775583],"about_ca_topic_score_codex":0.00029795963,"about_ca_topic_score_gemma":0.000067274996,"teacher_disagreement_score":0.7398429,"about_ca_system_score_codex":0.00023538593,"about_ca_system_score_gemma":0.00012525417,"threshold_uncertainty_score":0.5981671},"labels":[],"label_agreement":null},{"id":"W4380290882","doi":"10.2217/nmt-2023-0016","title":"Targeting Metabotropic Glutamate Receptors for the Treatment of Parkinson’s Disease","year":2023,"lang":"en","type":"editorial","venue":"Neurodegenerative Disease Management","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Metabotropic glutamate receptor; Neuroscience; Metabotropic receptor; Metabotropic glutamate receptor 2; Glutamate receptor; Ionotropic effect; Neurology; Metabotropic glutamate receptor 1; Medicine; Library science; Psychology; Receptor; Computer science; Internal medicine","score_opus":0.0482757096830858,"score_gpt":0.3458132350979046,"score_spread":0.2975375254148188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380290882","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01190367,0.0010709658,0.00017759146,0.0012795128,0.9764413,0.005593496,0.0032193395,0.00026181244,0.000052309235],"genre_scores_gemma":[0.037973527,0.17674495,0.00008693977,0.0017429655,0.7099863,0.020221433,0.0004780733,0.000933544,0.051832207],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935325,0.00091349625,0.000687637,0.0020942867,0.0017162106,0.0010558888],"domain_scores_gemma":[0.9933715,0.0043772673,0.00043731232,0.0010541475,0.00020517118,0.0005545912],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032366888,0.00075968227,0.00065419107,0.00038017464,0.00096459565,0.00021293071,0.0014208489,0.00010807192,0.00006793098],"category_scores_gemma":[0.0022565883,0.00052807195,0.00061548705,0.0008893395,0.0005954687,0.00016426569,0.00040575623,0.00036518974,0.000111862326],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017333942,0.0009369244,0.000030225681,0.00044321327,0.00011419069,0.0006575717,0.00007180797,0.0030546188,0.014497661,0.00039693346,0.97577226,0.0022912112],"study_design_scores_gemma":[0.0012355173,0.00061367004,0.00015755098,0.00003391785,0.000767985,7.162393e-8,0.000016610185,0.0036997362,0.017475387,0.00008316715,0.9755036,0.00041275573],"about_ca_topic_score_codex":0.0000057784046,"about_ca_topic_score_gemma":0.0000019217564,"teacher_disagreement_score":0.26645494,"about_ca_system_score_codex":0.0001585936,"about_ca_system_score_gemma":0.00030556956,"threshold_uncertainty_score":0.99971706},"labels":[],"label_agreement":null},{"id":"W4394716210","doi":"10.2217/nmt-2024-0005","title":"Glycine and clozapine: potential relevance for the treatment of Parkinson's disease","year":2024,"lang":"en","type":"editorial","venue":"Neurodegenerative Disease Management","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; McGill University Health Centre; Talon Pharmaceuticals (Canada)","funders":"","keywords":"Clozapine; Psychiatry; Medicine; MEDLINE; Schizophrenia (object-oriented programming); Psychology; Political science","score_opus":0.012632320902543114,"score_gpt":0.2793851781595325,"score_spread":0.2667528572569894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394716210","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029037477,0.20521118,0.0010905513,0.0133676985,0.72274005,0.01746915,0.010374829,0.00030185832,0.00040719006],"genre_scores_gemma":[0.09542938,0.40686774,0.0004951454,0.0021103497,0.44332424,0.008232148,0.00508821,0.00044199082,0.038010783],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974462,0.00007549457,0.0003829736,0.001109167,0.00064150675,0.00034469765],"domain_scores_gemma":[0.9982933,0.00033575777,0.0001537823,0.00069478975,0.000137981,0.00038439574],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000056451772,0.0005920111,0.0006149784,0.00012080478,0.00017709812,0.00006838518,0.00014644505,0.00010691742,0.000036416535],"category_scores_gemma":[0.00011306523,0.00034695235,0.0004788613,0.0001300043,0.00019640887,0.000034372824,0.00011454769,0.00017011909,0.0000145880795],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008759646,0.002125408,0.00023636363,0.0024192662,0.0015640426,0.0017184844,0.00003447867,0.00017400719,0.000015958081,0.00079554145,0.9643524,0.0178044],"study_design_scores_gemma":[0.0044707125,0.0020983038,0.004810046,0.0001405628,0.0065786606,3.1809805e-7,0.000008212769,0.0012942351,0.000021462272,0.00089228764,0.97943044,0.00025478937],"about_ca_topic_score_codex":0.0000060115335,"about_ca_topic_score_gemma":0.0000035912872,"teacher_disagreement_score":0.27941585,"about_ca_system_score_codex":0.00007958809,"about_ca_system_score_gemma":0.00009383341,"threshold_uncertainty_score":0.99989825},"labels":[],"label_agreement":null},{"id":"W4401716166","doi":"10.1080/17582024.2024.2389034","title":"A discussion with Philippe Huot: the challenges of discovering novel therapies for the treatment of Parkinson’s disease","year":2024,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Disease; Parkinson's disease; Medicine; Psychology; Psychotherapist; Intensive care medicine; Internal medicine","score_opus":0.03575226532805799,"score_gpt":0.2819761750557222,"score_spread":0.24622390972766423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401716166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77346474,0.14926057,0.01560593,0.045466002,0.00088634464,0.01195616,0.002321159,0.00020678485,0.00083231967],"genre_scores_gemma":[0.9889256,0.007999638,0.0001900658,0.00013482294,0.00013498623,0.0017210866,0.000050435458,0.000055315173,0.00078806205],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984131,0.000057200003,0.00025909374,0.0005641575,0.00044717433,0.00025928003],"domain_scores_gemma":[0.9988456,0.00010694419,0.00009776933,0.00068316836,0.00006377889,0.00020275608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087189335,0.0003463684,0.00031721644,0.000101900136,0.00019314329,0.000046662262,0.0001528116,0.000017460905,0.000022248405],"category_scores_gemma":[0.000009597293,0.0001288966,0.0003484437,0.00017993267,0.00015645732,0.00008640814,0.000055605167,0.000045433946,0.0000022034176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025519263,0.021234768,0.0094633065,0.008191487,0.017855696,0.0011620545,0.014259672,0.0057429234,0.005506397,0.3558272,0.0008958418,0.5343414],"study_design_scores_gemma":[0.010120595,0.0046638492,0.64483196,0.0018192148,0.013368344,0.000005696,0.0049114903,0.019836182,0.0063739833,0.0022405183,0.2910997,0.00072847935],"about_ca_topic_score_codex":0.000008093624,"about_ca_topic_score_gemma":0.000018278288,"teacher_disagreement_score":0.63536865,"about_ca_system_score_codex":0.000078278346,"about_ca_system_score_gemma":0.000087810564,"threshold_uncertainty_score":0.52562505},"labels":[],"label_agreement":null},{"id":"W4403141700","doi":"10.1080/17582024.2024.2404378","title":"Mapping the journey of patients and care partners living with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: developing a framework for improvements in care","year":2024,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Leukoencephalopathy; Spheroid; Medicine; Neuroscience; Psychology; Biology; Pathology; Genetics","score_opus":0.02656992698641835,"score_gpt":0.26886204923607115,"score_spread":0.2422921222496528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403141700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972124,0.00023913702,0.02494817,0.00044754136,0.00017596531,0.0018228907,0.00011477886,0.000059607988,0.00006792639],"genre_scores_gemma":[0.9947619,0.00018968117,0.0031288054,0.001309379,0.000030473086,0.00047290119,0.000023399998,0.00004556665,0.00003789672],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99786526,0.0002088725,0.0003411622,0.00080778106,0.00046851105,0.00030841207],"domain_scores_gemma":[0.99915487,0.00019938931,0.00013057484,0.00023006504,0.0001551508,0.00012995799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008803246,0.0003087684,0.00019974275,0.00020295638,0.0003268969,0.00024600996,0.00016862882,0.000028229972,0.0000054927564],"category_scores_gemma":[0.00012266326,0.00021466786,0.00003963329,0.00048428262,0.00012933029,0.00025555232,0.00016287317,0.00014331457,8.819551e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038491448,0.00090806704,0.14284422,0.016591173,0.00041824632,0.0011601712,0.08118609,0.01183107,0.070381954,0.6046158,0.0006436224,0.065570414],"study_design_scores_gemma":[0.0128460005,0.0045972625,0.3860706,0.008820903,0.0007589539,0.000031096286,0.060095202,0.049735926,0.46649274,0.0040012915,0.0027439618,0.003806058],"about_ca_topic_score_codex":0.0000020810658,"about_ca_topic_score_gemma":0.000035515128,"teacher_disagreement_score":0.60061455,"about_ca_system_score_codex":0.00006788295,"about_ca_system_score_gemma":0.00008764132,"threshold_uncertainty_score":0.8753901},"labels":[],"label_agreement":null},{"id":"W4412047533","doi":"10.1080/17582024.2025.2528557","title":"Recent and on-going trials for the treatment of levodopa-induced dyskinesia: a review of the clinical trial databases","year":2025,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Neurological Institute and Hospital; McGill University","funders":"","keywords":"Dyskinesia; Clinical trial; Levodopa; Medicine; Database; Computer science; Parkinson's disease; Disease; Internal medicine","score_opus":0.37262730765084734,"score_gpt":0.48677388211945816,"score_spread":0.11414657446861082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412047533","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011474412,0.9721695,0.00006250738,0.0006467266,0.0010700994,0.023769243,0.0018547581,0.000015937678,0.00029649033],"genre_scores_gemma":[0.00004757231,0.9931288,0.00013062368,0.0006773308,0.00032642286,0.004518351,0.00043066463,0.00004704118,0.0006932283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945758,0.0017178061,0.001978485,0.0009357709,0.0005312575,0.00026087495],"domain_scores_gemma":[0.99425066,0.0024061142,0.0013905222,0.0015608111,0.0001774183,0.0002145009],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001123659,0.00067026366,0.0037021646,0.00016002927,0.00017414517,0.000019177613,0.0002776889,0.00006902006,0.000054538956],"category_scores_gemma":[0.0015183551,0.00030378829,0.0022970252,0.00040764207,0.00010030723,0.00002654848,0.00017201046,0.0001273173,0.0000025637748],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059014205,0.0028478617,0.0000059501317,0.07017824,0.00290475,0.00004068037,0.000004730457,4.917461e-7,2.149561e-7,0.0013354378,0.0022121514,0.91456807],"study_design_scores_gemma":[0.017930195,0.0015702117,0.00010600068,0.053888705,0.042435378,9.4587136e-7,0.0000061394044,0.000009896259,0.000020180827,0.000015899644,0.88384163,0.00017484097],"about_ca_topic_score_codex":0.0000028992645,"about_ca_topic_score_gemma":0.0000022416564,"teacher_disagreement_score":0.91439325,"about_ca_system_score_codex":0.00013087194,"about_ca_system_score_gemma":0.0006248177,"threshold_uncertainty_score":0.9999414},"labels":[],"label_agreement":null},{"id":"W4412509421","doi":"10.1080/17582024.2025.2520709","title":"A drug evaluation narrative review of cladribine as a treatment for multiple sclerosis","year":2025,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cladribine; Multiple sclerosis; Drug; Narrative; Medicine; Intensive care medicine; Pharmacology; Internal medicine; Psychiatry; Philosophy; Linguistics","score_opus":0.18322779336882317,"score_gpt":0.432603153387454,"score_spread":0.2493753600186308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412509421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019082274,0.9631609,0.000054172797,0.0013321046,0.0002180894,0.03154431,0.0013963351,0.00005560504,0.0022194467],"genre_scores_gemma":[0.000041969124,0.9593004,0.00052248203,0.00085525063,0.00014774846,0.03034022,0.003093457,0.0000746839,0.0056237816],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99453306,0.0010459743,0.0012453658,0.0013506643,0.0013261323,0.00049879425],"domain_scores_gemma":[0.995949,0.0007069285,0.0006158022,0.0012008233,0.0011656481,0.00036181838],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007565913,0.00091139256,0.0031476552,0.0005813656,0.00025774815,0.000033173295,0.0002916405,0.000078351455,0.00020732435],"category_scores_gemma":[0.0022571413,0.0006636011,0.0017579882,0.0008545058,0.00015445109,0.000073230265,0.00032901665,0.00018537247,0.000016440152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024006,0.0008644217,0.0000035152054,0.34608257,0.0020938613,0.000013586793,0.00015792661,0.000005855823,0.000003489616,0.00016490789,0.031991042,0.61837876],"study_design_scores_gemma":[0.0033188867,0.0004497979,0.000092218,0.25381342,0.015717342,5.813375e-7,0.00011660873,0.00023997056,0.00003333539,0.000010492015,0.7258218,0.00038554397],"about_ca_topic_score_codex":0.0000167746,"about_ca_topic_score_gemma":0.000018825935,"teacher_disagreement_score":0.6938308,"about_ca_system_score_codex":0.00094280817,"about_ca_system_score_gemma":0.0011649149,"threshold_uncertainty_score":0.9995815},"labels":[],"label_agreement":null},{"id":"W4413832847","doi":"10.1080/17582024.2025.2552610","title":"Real-world safety and tolerability of intravenous edaravone in patients with amyotrophic lateral sclerosis","year":2025,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Tolerability; Amyotrophic lateral sclerosis; Edaravone; Medicine; Multiple sclerosis; Anesthesia; Adverse effect; Disease; Internal medicine; Psychiatry","score_opus":0.012566844088563105,"score_gpt":0.2552399923075464,"score_spread":0.2426731482189833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413832847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994119,0.000051495448,0.00007914461,0.0013235366,0.00005351171,0.0016164079,0.000048587255,0.000029528808,0.0026788274],"genre_scores_gemma":[0.99782795,0.0002722278,0.00029282403,0.00040672306,0.000018754105,0.00007884866,0.000068468704,0.000022173374,0.001012062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978379,0.00020019647,0.0004784649,0.00062449084,0.000499098,0.00035986953],"domain_scores_gemma":[0.99896663,0.000033347907,0.00008255312,0.0005164201,0.00017918454,0.00022183867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016568456,0.00024875163,0.00048563696,0.00038906548,0.000090808884,0.000035497455,0.0001263132,0.000032697062,0.00007171805],"category_scores_gemma":[0.000026140131,0.00019368596,0.00006029024,0.0007261526,0.00023369909,0.000095785304,0.00024445867,0.0002058747,0.0000029591647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008679545,0.0015532306,0.97273856,0.0006984916,0.00019734359,0.000059400576,0.00012768504,0.000553566,0.0006729876,0.0051123127,0.00011889268,0.009487994],"study_design_scores_gemma":[0.004304533,0.00037919002,0.9938302,0.00036308033,0.00012497521,6.2183375e-8,0.000009925748,0.0004320752,0.00019206919,0.00011302802,0.00010760473,0.00014323657],"about_ca_topic_score_codex":0.00015886956,"about_ca_topic_score_gemma":0.00007558083,"teacher_disagreement_score":0.021091668,"about_ca_system_score_codex":0.00022162627,"about_ca_system_score_gemma":0.00007556321,"threshold_uncertainty_score":0.7898285},"labels":[],"label_agreement":null},{"id":"W4416150722","doi":"10.1080/17582024.2025.2587549","title":"Identifying a combination of biomarkers to predict treatment response to nabilone for agitation in Alzheimer’s disease – an exploratory <i>post hoc</i> analysis","year":2025,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Centre for Addiction and Mental Health; Sunnybrook Health Science Centre","funders":"Alzheimer Society; Weston Brain Institute","keywords":"Disease; Exploratory analysis; Biomarker; MEDLINE; Clinical trial","score_opus":0.03510451417143287,"score_gpt":0.36031666314805205,"score_spread":0.3252121489766192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416150722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97498536,0.00026372707,0.012853091,0.0055067134,0.000099535355,0.0058030947,0.00027972,0.000041706484,0.00016705402],"genre_scores_gemma":[0.9920696,0.00004476349,0.0007944248,0.0022731049,0.000016404774,0.0035434947,0.00066089747,0.000023362658,0.00057397276],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99744743,0.00050480716,0.00044615802,0.00074744545,0.00052486314,0.00032926665],"domain_scores_gemma":[0.99812675,0.00010959458,0.000077866534,0.00048673002,0.00063893927,0.00056010875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005844401,0.00025133486,0.00035276884,0.0021619184,0.00011892432,0.0000702914,0.00013585693,0.000022104363,0.000026595773],"category_scores_gemma":[0.00025008366,0.0002434917,0.00020392702,0.002022613,0.000047480815,0.00020702048,0.00011947484,0.00004117497,0.000007542432],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36790827,0.02624829,0.31693256,0.0019748316,0.017011197,0.0010569217,0.0063528544,0.0098232925,0.084864214,0.0055171885,0.007127633,0.15518275],"study_design_scores_gemma":[0.005954448,0.0037422914,0.9696804,0.00018287428,0.005361252,6.0879294e-8,0.0017071606,0.003931107,0.008084118,0.000156526,0.00096269837,0.00023703501],"about_ca_topic_score_codex":0.000016714199,"about_ca_topic_score_gemma":0.000089648966,"teacher_disagreement_score":0.65274787,"about_ca_system_score_codex":0.00028006374,"about_ca_system_score_gemma":0.00020974182,"threshold_uncertainty_score":0.99293035},"labels":[],"label_agreement":null},{"id":"W4416224024","doi":"10.1080/17582024.2025.2580854","title":"Dancing through the darkness: a systematic review of dance as a multidimensional therapy for Parkinson’s disease","year":2025,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Dance; Dance therapy; Modalities; Disease; Treatment modality; Sample (material)","score_opus":0.027143982558418444,"score_gpt":0.36884427541214787,"score_spread":0.34170029285372944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416224024","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17109887,0.5595866,0.07784938,0.04101462,0.0073350864,0.11924706,0.0018142678,0.0006229655,0.021431135],"genre_scores_gemma":[0.8164813,0.065088116,0.0015152368,0.07348338,0.00028725324,0.027875418,0.00044124876,0.000088834204,0.0147392005],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965343,0.0012644342,0.00087199727,0.00055277447,0.00041025496,0.0003662336],"domain_scores_gemma":[0.997784,0.0004346895,0.00048858166,0.0008720006,0.00029993002,0.00012079065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073116453,0.00027989433,0.0005502101,0.000062830266,0.000766251,0.000012895336,0.00034606445,0.00003421545,0.000018696004],"category_scores_gemma":[0.00038437376,0.00018434762,0.00029341402,0.00032996252,0.00007935823,0.00013202959,0.00019723759,0.00017625003,0.000024167102],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092453277,0.0011755315,0.00096331973,0.76198447,0.00051337405,0.000021799215,0.00078880275,0.000033985416,0.0004528294,0.19561122,0.037080556,0.00044960197],"study_design_scores_gemma":[0.009466327,0.00022098041,0.21196234,0.6320024,0.004354869,4.523542e-7,0.002457808,0.0063677714,0.00006665147,0.022413801,0.109608546,0.001078063],"about_ca_topic_score_codex":0.000012111858,"about_ca_topic_score_gemma":0.0000070725646,"teacher_disagreement_score":0.64538246,"about_ca_system_score_codex":0.00009200616,"about_ca_system_score_gemma":0.00023266471,"threshold_uncertainty_score":0.7517478},"labels":[],"label_agreement":null},{"id":"W4416941498","doi":"10.1080/17582024.2025.2577054","title":"Practices and perceptions around splitting of carbidopa/levodopa tablets: a survey of patients and neurologists","year":2025,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Perception; Pill; Clinical Practice; MEDLINE; Best practice","score_opus":0.05320989404168995,"score_gpt":0.37125200439510636,"score_spread":0.3180421103534164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416941498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930537,0.0014135174,0.00006423438,0.0013922924,0.0000860051,0.0005373276,0.000098494114,0.000010462853,0.003343972],"genre_scores_gemma":[0.9964759,0.0020415063,0.00012059276,0.001091818,0.00001368925,0.000027911949,0.000032246524,0.0000072377943,0.00018911561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987956,0.00027880832,0.00027007368,0.00032553656,0.0001867942,0.00014317807],"domain_scores_gemma":[0.99892825,0.00034611038,0.0002692959,0.00016344717,0.00018333347,0.00010955491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002835574,0.00013301424,0.00025415217,0.00008347633,0.000112635076,0.000023091003,0.000052217343,0.00001740573,0.000015429125],"category_scores_gemma":[0.00088598195,0.00011167089,0.000031384712,0.00021754384,0.00017375761,0.0001140497,0.0002403833,0.00010604218,5.7414115e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011044537,0.00055624486,0.98937887,0.0009425075,0.00025217587,0.000019484833,0.000097245385,0.000027572925,0.00064394553,0.001313263,0.00042577548,0.0052384334],"study_design_scores_gemma":[0.0009840601,0.00017007206,0.99460346,0.000042609994,0.0005742938,3.080866e-7,0.00013867412,0.0014092159,0.00013972515,0.00004887211,0.0018183304,0.0000704052],"about_ca_topic_score_codex":0.0001812426,"about_ca_topic_score_gemma":0.000034734567,"teacher_disagreement_score":0.0052245352,"about_ca_system_score_codex":0.000012407648,"about_ca_system_score_gemma":0.00002192993,"threshold_uncertainty_score":0.45538068},"labels":[],"label_agreement":null}]}